|
HSP90AB2P expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.776000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.536300E-03 |
| Normal-vs-Stage2 |
7.979700E-02 |
| Normal-vs-Stage3 |
7.442800E-01 |
| Normal-vs-Stage4 |
6.253800E-02 |
| Stage1-vs-Stage2 |
7.646200E-01 |
| Stage1-vs-Stage3 |
4.092100E-02 |
| Stage1-vs-Stage4 |
3.7249000000017E-06 |
| Stage2-vs-Stage3 |
1.377610E-01 |
| Stage2-vs-Stage4 |
5.402400E-03 |
| Stage3-vs-Stage4 |
4.586300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.998210E-01 |
| Normal-vs-AfricanAmerican |
3.077900E-02 |
| Normal-vs-Asian |
9.349600E-01 |
| Caucasian-vs-AfricanAmerican |
8.824000E-02 |
| Caucasian-vs-Asian |
7.970000E-01 |
| AfricanAmerican-vs-Asian |
4.122400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.633000E-01 |
| Normal-vs-Female |
3.092000E-02 |
| Male-vs-Female |
1.948580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.767000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.216100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.922970E-01 |
| Normal-vs-Age(81-100Yrs) |
4.174100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.249600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.251000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.847600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.734800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.583300E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.723400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.904000E-02 |
| Normal-vs-Grade 2 |
4.020300E-03 |
| Normal-vs-Grade 3 |
2.194000E-01 |
| Normal-vs-Grade 4 |
4.970300E-02 |
| Grade 1-vs-Grade 2 |
8.831200E-01 |
| Grade 1-vs-Grade 3 |
5.277000E-01 |
| Grade 1-vs-Grade 4 |
2.584200E-02 |
| Grade 2-vs-Grade 3 |
1.333240E-01 |
| Grade 2-vs-Grade 4 |
5.7103999999919E-05 |
| Grade 3-vs-Grade 4 |
3.598600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.301700E-03 |
| Normal-vs-ccB subtype |
9.860800E-01 |
| ccA subtype-vs-ccB subtype |
1.923030E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.022780E-01 |
| Normal-vs-N1 |
4.081800E-02 |
| N0-vs-N1 |
6.317500E-03 |
|
|
